[1] ABDEL-WAHAB O,LEVINE R L.Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia[J].Blood,2013,121(18):3563-3572. [2] GREENBLATT S M,NIMER S D.Chromatin modifiers and the promise of epigenetic therapy in acute leukemia[J].Leukemia,2014,28(7):1396-1406. [3] DOMBRET H,SEYMOUR J F,BUTRYM A,et al.International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts[J].Blood,2015,126(3):291-299. [4] HE J M,XIU L,DE PORRE P,et al.Decitabine reduces transfusion dependence in older patients with acute myeloid leukemia:results from a post hoc analysis of a randomized phase III study[J].Leuk Lymphoma,2015,56(4):1033-1042. [5] MCCABE M T,OTT H M,GANJI G,et al.EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations[J].Nature,2012,492(7427):108-112. [6] HARRIS W J,HUANG X,LYNCH J T,et al.The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells[J].Cancer Cell,2012,21(4):473-487. [7] VANNINI E,PANIGHINI A,CERRI C,et al.The bacterial protein toxin,cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model[J].BMC Cancer,2014,14:449. [8] PETERS D E,HOOVER B,CLOUD L G,et al.Comparative toxicity and efficacy of engineered Anthrax lethal toxin variants with broad anti-tumor activities[J].Toxicol Appl Pharmacol,2014,279(2):220-229. [9] MA X L,CHANG W J,ZHANG C P,et al.Staphylococcal Panton-Valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils[J].PLoS One,2012,7(4):e34970. [10] SPAAN A N,HENRY T,VAN Rooijen W J M,et al.The staphylococcal toxin panton-valentine leukocidin targets human C5a receptors[J].Cell Host Microbe,2013,13(5):584-594. [11] BU S,XIE Q,CHANG W J,et al.LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells[J].Int J Biochem Cell Biol,2013,45(8):1531-1537. [12] SHAN W L,BU S,ZHANG C F,et al.LukS-PV,a component of Panton-Valentine leukocidin,exerts potent activity against acute myeloid leukemia in vitro and in vivo[J].Int J Biochem Cell Biol,2015,61:20-28. [13] DAI C Y,ZHANG C F,SUN X X,et al.LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN/c-FOS in human acute myeloid leukemia cells[J].Int J Biochem Cell Biol,2016,76:107-114. [14] SUN X X,ZHANG S S,DAI C Y,et al.LukS-PV-regulated MicroRNA-125a-3p promotes THP-1 macrophages differentiation and apoptosis by down-regulating NF1 and bcl-2[J].Cell Physiol Biochem,2017,44(3):1093-1105. [15] NISHIOKA K,RICE J C,SARMA K,et al.PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin[J].Mol Cell,2002,9(6):1201-1213. [16] YANG F,SUN L Y,Li Q,et al.SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities[J].EMBO J,2012,31(1):110-123. [17] LI Z F,NIE F,WANG S,et al.Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation[J].Proc Natl Acad Sci USA,2011,108(8):3116-3123. [18] ZHOU H R,FU H Y,WU D S,et al.Relationship between epigenetic changes in Wnt antagonists and acute leukemia[J].Oncol Rep,2017,37(5):2663-2671. [19] ITAHANA Y,ZHANG J Q,GÖKE J,et al.Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells[J].Sci Rep,2016,6:28112. [20] TAKAWA M,CHO HS,HAYAMI S,et al.Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression[J].Cancer research,2012,72:3217-3227. [21] WANG C,GUO Z,WU C,LI Y,KANG S.A polymorphism at the miR-502 binding site in the 3′untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer[J].Cancer Genet,2012,205. [22] YU N,HUANGYANG P W,YANG X H,et al.microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8[J].J Biol Chem,2013,288(27):19633-19642. [23] LIN H N,SU X Y,HE B.Protein lysine acylation and cysteine succination by intermediates of energy metabolism[J].ACS Chem Biol,2012,7(6):947-960. [24] DAI L Z,PENG C,MONTELLIER E,et al.Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark[J].Nat Chem Biol,2014,10(5):365-370. [25] KRIVTSOV A V,ARMSTRONG S A.MLL translocations,histone modifications and leukaemia stem-cell development[J].Nat Rev Cancer,2007,7(11):823-833. [26] ZHANG S L,GUO Z J,XU J S,et al.miR-502-mediated histone methyltransferase SET8 expression is associated with clear cell renal cell carcinoma risk[J].Oncol Lett,2017:7131-7138. |